Dr. Soliman Abdul Kader Fakeeh Hospital Co.

Dr. Soliman Abdul Kader Fakeeh Hospital Co. (Fakeeh Care) is a leading private healthcare provider in Saudi Arabia, operating a network of hospitals, medical centers, and pharmacies. Founded in 1978, the company offers a comprehensive range of medical services, including general and specialized surgery, cardiology, oncology, pediatrics, and emergency care. Its flagship facility is the Dr. Soliman Fakeeh Hospital in Jeddah, a renowned tertiary care hospital with advanced medical technologies and accreditation from the Joint Commission International (JCI). The company also manages the Fakeeh Care chain of medical centers and pharmacies across the Kingdom, positioning itself as a trusted name in Saudi healthcare.

The company generates revenue primarily from patient care services, including inpatient and outpatient treatments, diagnostic services, and surgical procedures. Additional revenue streams come from pharmacy sales, laboratory services, and rental income from medical facilities. The business model relies on a mix of private pay, insurance contracts, and government referrals, with a growing focus on health insurance partnerships. Revenue is recognized upon delivery of services, with a significant portion coming from high-complexity procedures and chronic disease management. The recent financial data shows quarterly revenues around SAR 700-800 million, with net income varying due to operational costs and seasonal factors.

Fakeeh Care operates in the healthcare sector, specifically in the medical care facilities industry, competing with other private hospital groups like Saudi German Hospital, Dallah Healthcare, and Al Hammadi Company. The company differentiates itself through its long-standing reputation, JCI accreditation, and specialized centers of excellence in cardiology, oncology, and minimally invasive surgery. Its competitive positioning is strengthened by a loyal patient base and strategic location in Jeddah, a major economic hub. However, the industry faces challenges from rising operational costs, regulatory changes, and competition from public healthcare expansion. The company's financial metrics show moderate profitability with a profit margin of 8.77% and an EV/EBITDA of 22.21, indicating a premium valuation relative to earnings.

The primary customers are Saudi nationals and expatriates residing in the Western Region, particularly Jeddah and Makkah, seeking high-quality private healthcare. The company also serves medical tourists from neighboring Gulf countries and beyond, attracted by its specialized services. Key geographic markets are concentrated in the Western Province, with plans to expand to other regions. The target audience includes individuals with private health insurance, corporate clients, and government-sponsored patients. The company's revenue is sensitive to population growth, health awareness, and insurance penetration in Saudi Arabia, as part of the Vision 2030 healthcare transformation.

An auto-generated descriptive profile based on company data, for informational purposes only.